Skip to main content
Caplight Logo









Guangzhou Sinogen Pharmaceutical Co., Ltd.

Guangzhou Sinogen Pharmaceutical Co., Ltd.

Private
GuangzhouHealthcare & Life Scienceshttps://huajinpharmtech.com/

Last Round

Series B

Dec 1, 2023

Company Overview

Guangzhou Sinogen Pharmaceutical Co., Ltd. is a biotechnology company that focuses on the research, development, and production of innovative biological oncology drugs, specifically tumor-targeting oncolytic bacteria.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

oncolytic bacteriaoncolytic viruscancer immunotherapysolid tumor treatmentbiotech R&Ddrug discoveryclinical trialspreclinical evaluationgenetic engineeringbioinformaticsonco-immunologydrug licensingGMP manufacturingprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Guangzhou Sinogen Pharmaceutical Co., Ltd. Comparables

Compare Guangzhou Sinogen Pharmaceutical Co., Ltd. with similar companies based on industry and business-model similarity.

Guangzhou Sinogen Pharmaceutical Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Shaoxing Salvectors Biotechnology Ltd.
84%
TILT Biotherapeutics
83%
BioMed Valley Discoveries
80%

Guangzhou Sinogen Pharmaceutical Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BDec 1, 2023
VC RoundMay 1, 2022
Series ASep 1, 2020
AngelSep 1, 2017

Guangzhou Sinogen Pharmaceutical Co., Ltd. Investors

Notable investors and investment history

Guangzhou Sinogen Pharmaceutical Co., Ltd. investors
InvestorRounds
Zhejiang Sino Wisdom Investment ManagementVC Round
河北沿海产业投资基金管理有限公司Series B
CICC CapitalSeries A
Winzac Capital ManagementSeries A
Share CapitalAngel

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 1, 2023

    Secured Series B funding from 河北沿海产业投资基金管理有限公司.

  • Sep 1, 2020

    Raised Series A with CICC Capital and Winzac Capital Management.

Guangzhou Sinogen Pharmaceutical Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Guangzhou Sinogen Pharmaceutical Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Guangzhou Sinogen Pharmaceutical Co., Ltd.'s valuation, stock price, and market status.

Is Guangzhou Sinogen Pharmaceutical Co., Ltd. a public or private company?

Guangzhou Sinogen Pharmaceutical Co., Ltd. is a private company.

What is the current stock price of Guangzhou Sinogen Pharmaceutical Co., Ltd.?

Guangzhou Sinogen Pharmaceutical Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.

How much is Guangzhou Sinogen Pharmaceutical Co., Ltd. worth (valuation)?

Valuation information for Guangzhou Sinogen Pharmaceutical Co., Ltd. is not publicly available.

Can I buy Guangzhou Sinogen Pharmaceutical Co., Ltd. stock?

Guangzhou Sinogen Pharmaceutical Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Guangzhou Sinogen Pharmaceutical Co., Ltd.'s last funding round?

Guangzhou Sinogen Pharmaceutical Co., Ltd.'s most recent funding round was Series B on December 1, 2023.

Who are the main investors in Guangzhou Sinogen Pharmaceutical Co., Ltd.?

Key investors in Guangzhou Sinogen Pharmaceutical Co., Ltd. include Zhejiang Sino Wisdom Investment Management, 河北沿海产业投资基金管理有限公司, CICC Capital, Winzac Capital Management, Share Capital.

Will Guangzhou Sinogen Pharmaceutical Co., Ltd. IPO soon?

No public IPO plans have been announced for Guangzhou Sinogen Pharmaceutical Co., Ltd..

How can I track Guangzhou Sinogen Pharmaceutical Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Guangzhou Sinogen Pharmaceutical Co., Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGuangzhou
Year Founded2016
Last FundingDec 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?